Ritholtz Wealth Management Has $1.37 Million Stake in Danaher Co. (NYSE:DHR)

Ritholtz Wealth Management lessened its position in shares of Danaher Co. (NYSE:DHR - Free Report) by 18.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,947 shares of the conglomerate's stock after selling 1,335 shares during the period. Ritholtz Wealth Management's holdings in Danaher were worth $1,365,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the company. FMR LLC boosted its stake in shares of Danaher by 15.8% during the 3rd quarter. FMR LLC now owns 23,617,424 shares of the conglomerate's stock worth $6,566,116,000 after buying an additional 3,217,631 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its position in Danaher by 17.6% during the third quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate's stock valued at $996,141,000 after purchasing an additional 535,254 shares during the last quarter. International Assets Investment Management LLC grew its stake in Danaher by 40,196.5% in the third quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate's stock valued at $119,539,000 after purchasing an additional 428,897 shares in the last quarter. Montrusco Bolton Investments Inc. increased its position in shares of Danaher by 30.4% during the 3rd quarter. Montrusco Bolton Investments Inc. now owns 1,705,884 shares of the conglomerate's stock worth $465,617,000 after purchasing an additional 397,671 shares during the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec raised its stake in shares of Danaher by 82.4% during the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 653,375 shares of the conglomerate's stock worth $181,651,000 after purchasing an additional 295,187 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors.

Danaher Price Performance

Shares of NYSE DHR traded down $3.49 during midday trading on Friday, reaching $238.41. The company's stock had a trading volume of 3,044,734 shares, compared to its average volume of 2,640,177. The company has a market cap of $172.20 billion, a P/E ratio of 45.50, a P/E/G ratio of 4.23 and a beta of 0.83. Danaher Co. has a fifty-two week low of $222.53 and a fifty-two week high of $281.70. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The business's 50 day moving average price is $234.85 and its two-hundred day moving average price is $253.42.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating analysts' consensus estimates of $1.57 by $0.14. The firm had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The company's revenue was up 3.1% compared to the same quarter last year. During the same period in the prior year, the company posted $2.02 EPS. On average, analysts forecast that Danaher Co. will post 7.49 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be given a $0.27 dividend. This represents a $1.08 annualized dividend and a dividend yield of 0.45%. The ex-dividend date is Friday, December 27th. Danaher's payout ratio is presently 20.61%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the stock. UBS Group lowered their target price on shares of Danaher from $309.00 to $305.00 and set a "buy" rating on the stock in a report on Wednesday, October 23rd. KeyCorp raised their target price on shares of Danaher from $290.00 to $310.00 and gave the company an "overweight" rating in a research note on Wednesday, October 23rd. Scotiabank started coverage on Danaher in a research report on Monday, December 23rd. They set a "sector perform" rating and a $265.00 price target on the stock. Raymond James cut their price objective on Danaher from $310.00 to $300.00 and set an "outperform" rating for the company in a research report on Wednesday, October 23rd. Finally, Stephens restated an "overweight" rating and issued a $315.00 price target on shares of Danaher in a research note on Wednesday, October 23rd. Six equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, Danaher currently has a consensus rating of "Moderate Buy" and a consensus price target of $286.80.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.